CLASS II Drug recall · Reported 28 Feb 2018 · FDA Enforcement Report

Ascorbic Acid USP, for prescription compounding recalled

American Pharmaceutical Ingredients is recalling Ascorbic Acid USP, for prescription compounding, distributed nationwide in the US. The recall was initiated on 9 Feb 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: b) 030816-1, Exp. 05/20/2018; c) 030816-1, Exp. 05/20/2018; d) 030816-3, Exp. 05/20/2018; e) 030816-2, Exp. 05/20/2018;
Quantity recalled200000 g

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0535-2018
FDA event ID
79149
Recalling firm
American Pharmaceutical Ingredients, Waterford, MI
Classification
Class II
Status
Terminated
Recall initiated
9 Feb 2018
FDA classified
22 Feb 2018
Reported
28 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

9 Feb 2018Recall initiated by company
22 Feb 2018Classified by FDA+13 days
28 Feb 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Ascorbic Acid USP, for prescription compounding, packaged in a) 100g (NDC 58597-8120-6); b) 500g (NDC 58597-8120-7); c) 1000g (NDC 58597-8120-8); d) 5000g (NDC 58597-8120-9); e) 25000g (NDC 58597-8120-3), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Where it was distributed

Nationwide within USA.

Nationwide

Questions about this recall

Is Ascorbic Acid USP, for prescription compounding recalled?

Yes. American Pharmaceutical Ingredients recalled Ascorbic Acid USP, for prescription compounding on 9 Feb 2018. The recall is Class II and its status is Terminated. Recall number D-0535-2018.

Why was it recalled?

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Which lots are affected?

Lot #: b) 030816-1, Exp. 05/20/2018; c) 030816-1, Exp. 05/20/2018; d) 030816-3, Exp. 05/20/2018; e) 030816-2, Exp. 05/20/2018;

Where was it sold?

Nationwide within USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from American Pharmaceutical Ingredients

All 71

Other Ascorbic acid recalls

All 4